Organovo Holdings Files 8-K on Officer/Director Changes
Ticker: VIVS · Form: 8-K · Filed: Dec 31, 2024 · CIK: 1497253
| Field | Detail |
|---|---|
| Company | Organovo Holdings, Inc. (VIVS) |
| Form Type | 8-K |
| Filed Date | Dec 31, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $450.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-governance, filing
Related Tickers: ONVO
TL;DR
Organovo Holdings (ONVO) filed an 8-K detailing leadership changes and financial statements.
AI Summary
Organovo Holdings, Inc. filed an 8-K on December 23, 2024, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors or officers can signal internal shifts or strategic realignments that may affect the company's future performance.
Key Numbers
- 001-35996 — SEC File Number (Identifies the company's filing history with the SEC.)
- 27-1488943 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Organovo Holdings, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- December 23, 2024 (date) — Date of earliest event reported
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates events related to the departure of directors or certain officers, election of directors, and appointment of certain officers.
What is the date of the earliest event reported in this 8-K?
The earliest event reported is December 23, 2024.
What is the company's principal executive office address?
The principal executive office is located at 11555 Sorrento Valley Rd Suite 100, San Diego, California, 92121.
What is Organovo Holdings, Inc.'s fiscal year end?
Organovo Holdings, Inc.'s fiscal year ends on March 31st.
What other information is included in this filing besides officer and director changes?
The filing also includes information on compensatory arrangements of certain officers and financial statements and exhibits.
Filing Stats: 976 words · 4 min read · ~3 pages · Grade level 11.3 · Accepted 2024-12-31 08:05:06
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value ONVO The Nasdaq Stock Mar
- $450.00 — the Company has agreed to pay Danforth $450.00 per hour of services provided by Mr. St
Filing Documents
- onvo-20241223.htm (8-K) — 49KB
- onvo-ex10_2.htm (EX-10.2) — 32KB
- 0000950170-24-141323.txt ( ) — 197KB
- onvo-20241223.xsd (EX-101.SCH) — 24KB
- onvo-20241223_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 10.1 Consulting Agreement dated August 25, 2020 by and between Company and Danforth Advisors, LLC (incorporated by reference from Exhibit 10.2 to the Company 's Quarterly Report on Form 10-Q,as filed with the SEC on November 5, 2020) 10.2 Amendment No. 6 to the Consulting Agreement, dated December 30, 2024 by and between Company and Danforth Advisors, LLC 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGANOVO HOLDINGS, INC. Date: December 31, 2024 By: /s/ Keith Murphy Keith Murphy Executive Chairman